Reviews: Gerotarget (Focus on Aging):
Reprogramming of energy metabolism as a driver of aging
Metrics: PDF 1404 views | HTML 1885 views | ?
Zhaoyang Feng1, Richard W. Hanson2,3,*, Nathan A. Berger2,3,4 and Alexander Trubitsyn5
1 Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
2 Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
3 Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
4 Department of Medicine, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
5 Institute of Biology and Soil Sciences of Far Eastern Brach of Russian Academy of Science, Vladivostok, Russia
Zhaoyang Feng, email:
Keywords: aging, energy metabolism, mitochondria, glycolysis, physical activity, Gerotarget
Received: January 22, 2016 Accepted: February 11, 2016 Published: February 23, 2016
Aging is characterized by progressive loss of cellular function and integrity. It has been thought to be driven by stochastic molecular damage. However, genetic and environmental maneuvers enhancing mitochondrial function or inhibiting glycolysis extend lifespan and promote healthy aging in many species. In post-fertile Caenorhabditis elegans, a progressive decline in phosphoenolpyruvate carboxykinase with age, and a reciprocal increase in pyruvate kinase shunt energy metabolism from oxidative metabolism to anaerobic glycolysis. This reduces the efficiency and total of energy generation. As a result, energy-dependent physical activity and other cellular functions decrease due to unmatched energy demand and supply. In return, decrease in physical activity accelerates this metabolic shift, forming a vicious cycle. This metabolic event is a determinant of aging, and is retarded by caloric restriction to counteract aging. In this review, we summarize these and other evidence supporting the idea that metabolic reprogramming is a driver of aging. We also suggest strategies to test this hypothesis
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.